US Stock MarketDetailed Quotes

ALLO Allogene Therapeutics

Watchlist
  • 2.350
  • 0.0000.00%
Close Jan 8 16:00 ET
  • 2.350
  • 0.0000.00%
Post 20:01 ET
492.73MMarket Cap-1.52P/E (TTM)

Allogene Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
-26.67%22K
-39.10%95K
152.50%21K
-55.10%22K
-74.42%22K
-50.82%30K
-99.86%156K
-100.05%-40K
Operating revenue
--0
--0
-26.67%22K
-39.10%95K
152.50%21K
-55.10%22K
-74.42%22K
-50.82%30K
-99.86%156K
-100.05%-40K
Cost of revenue
Gross profit
Operating expense
-3.13%61.05M
-17.53%66.44M
-29.86%69.53M
-6.29%314.59M
-25.45%71.89M
-23.65%63.02M
5.06%80.56M
23.82%99.12M
14.07%335.69M
30.40%96.42M
Selling and administrative expenses
-4.15%16.33M
-13.16%16.09M
-8.56%17.27M
-9.62%71.67M
-17.99%17.22M
-9.82%17.04M
-5.05%18.52M
-5.09%18.88M
7.02%79.31M
5.22%21M
-General and administrative expense
-4.15%16.33M
-13.16%16.09M
-8.56%17.27M
-9.62%71.67M
-17.99%17.22M
-9.82%17.04M
-5.05%18.52M
-5.09%18.88M
7.02%79.31M
5.22%21M
Research and development costs
-2.75%44.71M
-18.83%50.36M
-34.87%52.26M
-5.25%242.91M
-27.52%54.66M
-27.76%45.98M
8.51%62.04M
33.38%80.24M
16.45%256.39M
39.71%75.42M
Operating profit
3.10%-61.05M
17.50%-66.44M
29.86%-69.5M
6.27%-314.49M
25.50%-71.86M
23.63%-63M
-5.15%-80.54M
-23.88%-99.09M
-86.21%-335.54M
-5,750.91%-96.46M
Net non-operating interest income expense
6.45%6.61M
32.03%4.99M
163.87%5.43M
300.94%18.31M
127.24%6.27M
519.26%6.21M
1,099.37%3.78M
318.50%2.06M
166.39%4.57M
1,382.26%2.76M
Non-operating interest income
8.06%6.71M
32.03%4.99M
163.87%5.43M
300.94%18.31M
127.24%6.27M
519.26%6.21M
1,099.37%3.78M
318.50%2.06M
166.39%4.57M
1,382.26%2.76M
Non-operating interest expense
--100K
----
----
----
----
--0
----
----
----
----
Other net income (expense)
-115.65%-11.85M
-98.54%-4.9M
68.35%-929K
-229.10%-31.08M
-126.10%-20.18M
-230.89%-5.5M
-265.55%-2.47M
-738.57%-2.94M
-164.32%-9.44M
-393.91%-8.93M
Special income (charges)
---10.73M
---4.99M
----
---13.25M
---13.25M
--0
--0
----
----
----
-Less:Impairment of capital assets
--10.73M
--4.99M
----
--13.25M
--13.25M
--0
--0
----
----
----
Other non- operating income (expenses)
79.55%-1.12M
103.44%85K
68.35%-929K
-88.85%-17.84M
22.31%-6.93M
-230.89%-5.5M
-265.55%-2.47M
-738.57%-2.94M
-164.32%-9.44M
-393.91%-8.93M
Income before tax
-6.43%-66.29M
16.25%-66.36M
34.98%-65M
3.86%-327.27M
16.42%-85.78M
25.09%-62.29M
-5.94%-79.23M
-25.19%-99.97M
-86.99%-340.41M
-119,436.05%-102.63M
Income tax
Net income
-6.43%-66.29M
16.25%-66.36M
34.98%-65M
3.86%-327.27M
16.42%-85.78M
25.09%-62.29M
-5.94%-79.23M
-25.19%-99.97M
-86.99%-340.41M
-119,436.05%-102.63M
Net income continuous Operations
-6.43%-66.29M
16.25%-66.36M
34.98%-65M
3.86%-327.27M
16.42%-85.78M
25.09%-62.29M
-5.94%-79.23M
-25.19%-99.97M
-86.99%-340.41M
-119,436.05%-102.63M
Minority interest income
Net income attributable to the parent company
-6.43%-66.29M
16.25%-66.36M
34.98%-65M
3.86%-327.27M
16.42%-85.78M
25.09%-62.29M
-5.94%-79.23M
-25.19%-99.97M
-86.99%-340.41M
-119,436.05%-102.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-6.43%-66.29M
16.25%-66.36M
34.98%-65M
3.86%-327.27M
16.42%-85.78M
25.09%-62.29M
-5.94%-79.23M
-25.19%-99.97M
-86.99%-340.41M
-119,436.05%-102.63M
Basic earnings per share
13.51%-0.32
35.19%-0.35
44.93%-0.38
12.18%-2.09
22.73%-0.51
36.21%-0.37
-3.85%-0.54
-23.21%-0.69
-77.61%-2.38
-22.22%-0.66
Diluted earnings per share
13.51%-0.32
35.19%-0.35
44.93%-0.38
12.18%-2.09
22.73%-0.51
36.21%-0.37
-3.85%-0.54
-23.21%-0.69
-77.61%-2.38
-22.22%-0.66
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Total revenue 0 0 -26.67%22K -39.10%95K 152.50%21K -55.10%22K -74.42%22K -50.82%30K -99.86%156K -100.05%-40K
Operating revenue --0 --0 -26.67%22K -39.10%95K 152.50%21K -55.10%22K -74.42%22K -50.82%30K -99.86%156K -100.05%-40K
Cost of revenue
Gross profit
Operating expense -3.13%61.05M -17.53%66.44M -29.86%69.53M -6.29%314.59M -25.45%71.89M -23.65%63.02M 5.06%80.56M 23.82%99.12M 14.07%335.69M 30.40%96.42M
Selling and administrative expenses -4.15%16.33M -13.16%16.09M -8.56%17.27M -9.62%71.67M -17.99%17.22M -9.82%17.04M -5.05%18.52M -5.09%18.88M 7.02%79.31M 5.22%21M
-General and administrative expense -4.15%16.33M -13.16%16.09M -8.56%17.27M -9.62%71.67M -17.99%17.22M -9.82%17.04M -5.05%18.52M -5.09%18.88M 7.02%79.31M 5.22%21M
Research and development costs -2.75%44.71M -18.83%50.36M -34.87%52.26M -5.25%242.91M -27.52%54.66M -27.76%45.98M 8.51%62.04M 33.38%80.24M 16.45%256.39M 39.71%75.42M
Operating profit 3.10%-61.05M 17.50%-66.44M 29.86%-69.5M 6.27%-314.49M 25.50%-71.86M 23.63%-63M -5.15%-80.54M -23.88%-99.09M -86.21%-335.54M -5,750.91%-96.46M
Net non-operating interest income expense 6.45%6.61M 32.03%4.99M 163.87%5.43M 300.94%18.31M 127.24%6.27M 519.26%6.21M 1,099.37%3.78M 318.50%2.06M 166.39%4.57M 1,382.26%2.76M
Non-operating interest income 8.06%6.71M 32.03%4.99M 163.87%5.43M 300.94%18.31M 127.24%6.27M 519.26%6.21M 1,099.37%3.78M 318.50%2.06M 166.39%4.57M 1,382.26%2.76M
Non-operating interest expense --100K ---- ---- ---- ---- --0 ---- ---- ---- ----
Other net income (expense) -115.65%-11.85M -98.54%-4.9M 68.35%-929K -229.10%-31.08M -126.10%-20.18M -230.89%-5.5M -265.55%-2.47M -738.57%-2.94M -164.32%-9.44M -393.91%-8.93M
Special income (charges) ---10.73M ---4.99M ---- ---13.25M ---13.25M --0 --0 ---- ---- ----
-Less:Impairment of capital assets --10.73M --4.99M ---- --13.25M --13.25M --0 --0 ---- ---- ----
Other non- operating income (expenses) 79.55%-1.12M 103.44%85K 68.35%-929K -88.85%-17.84M 22.31%-6.93M -230.89%-5.5M -265.55%-2.47M -738.57%-2.94M -164.32%-9.44M -393.91%-8.93M
Income before tax -6.43%-66.29M 16.25%-66.36M 34.98%-65M 3.86%-327.27M 16.42%-85.78M 25.09%-62.29M -5.94%-79.23M -25.19%-99.97M -86.99%-340.41M -119,436.05%-102.63M
Income tax
Net income -6.43%-66.29M 16.25%-66.36M 34.98%-65M 3.86%-327.27M 16.42%-85.78M 25.09%-62.29M -5.94%-79.23M -25.19%-99.97M -86.99%-340.41M -119,436.05%-102.63M
Net income continuous Operations -6.43%-66.29M 16.25%-66.36M 34.98%-65M 3.86%-327.27M 16.42%-85.78M 25.09%-62.29M -5.94%-79.23M -25.19%-99.97M -86.99%-340.41M -119,436.05%-102.63M
Minority interest income
Net income attributable to the parent company -6.43%-66.29M 16.25%-66.36M 34.98%-65M 3.86%-327.27M 16.42%-85.78M 25.09%-62.29M -5.94%-79.23M -25.19%-99.97M -86.99%-340.41M -119,436.05%-102.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -6.43%-66.29M 16.25%-66.36M 34.98%-65M 3.86%-327.27M 16.42%-85.78M 25.09%-62.29M -5.94%-79.23M -25.19%-99.97M -86.99%-340.41M -119,436.05%-102.63M
Basic earnings per share 13.51%-0.32 35.19%-0.35 44.93%-0.38 12.18%-2.09 22.73%-0.51 36.21%-0.37 -3.85%-0.54 -23.21%-0.69 -77.61%-2.38 -22.22%-0.66
Diluted earnings per share 13.51%-0.32 35.19%-0.35 44.93%-0.38 12.18%-2.09 22.73%-0.51 36.21%-0.37 -3.85%-0.54 -23.21%-0.69 -77.61%-2.38 -22.22%-0.66
Dividend per share
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- -- -- -- -- -- Unqualified Opinion --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Symbol Mini Chart % Chg
Toll Brothers
TOL
+2.56%
Meritage Homes
MTH
+2.34%
Taylor Morrison Home
TMHC
+1.58%
D.R. Horton
DHI
+1.49%
KB Home
KBH
+1.35%

Unlock the Full List